Methyl 2-(bromomethyl)nicotinate, 95.0%, 1g

2-Amino-6-fluorobenzonitrile, 97.0%, 25g

(R)-METHYL 2-(2-CHLOROPHENYL)-2-HYDROXYACETATE, 95.0%, 100g

(R)-N-(1-Amino-1,2-diphenylethyl)methanesulfonamide, 98+%, 5g

6-Bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one, 95.0%, 10g

2-cyclohexanecarbonyl-1H,2H,3H,4H,6H,7H,11bH-piperazino[2,1-a]isoquinolin-4-one, 98.0%, 5g

2-Chloro-6-trifluoromethylnicotinonitrile, 95.0%, 250mg

2-Methyl-2,3-dihydrobenzofuran-7-amine, 95%, 1g

6-FLUORO-3-METHYL-2-PHENYLQUINOLINE-4-CARBOXYLIC ACID, 95.0%, 250mg

3-Bromo-4-chlorobenzenesulfonamide, 250mg

Colonna HPLC NUCLEODUR® NH2 5 µm, 150 mm, 4,6 mm, 1 Pezzo(i)

6-Hydroxy-2-oxo-4-phenyl-1,2-dihydro-pyridine-3,5-dicarbonitrile, 250mg

2-Bromo-6-methylpyridin-3-amine, 97.0%, 5g